Sort
11,323 grants matching “glioblastoma”
Integrated Immune Engineering for Poor Prognosis Cancers
$1,921,029David J Odde · University Of Minnesota · P01 · FY2021 · CA
Neurosurgical Oncology Unit
$1,913,214Desmond Brown · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
p53, Aging, and Cancer
$1,912,927Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
$1,912,533Theodore S Hong · Massachusetts General Hospital · U19 · FY2016 · CA
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
$1,910,960Joseph J Cullen · University Of Iowa · P01 · FY2022 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,907,279David J Odde · University Of Minnesota · P01 · FY2025 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,905,452E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2018 · CA
Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu
$1,901,909Forest M White · Massachusetts Institute Of Technology · U54 · FY2024 · CA
Novel Therapeutics for Prion Diseases
$1,899,821Stanley B Prusiner · University Of California, San Francisco · P01 · FY2011 · AG
Novel Therapeutics for Prion Diseases
$1,895,717Stanley B Prusiner · University Of California, San Francisco · P01 · FY2009 · AG
System Biology Center in New York
$1,895,086Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · P50 · FY2015 · GM
System Biology Center in New York
$1,894,201Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · P50 · FY2016 · GM
System Biology Center in New York
$1,894,035Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · P50 · FY2017 · GM
Systems analysis of phenotypic switch in control of cancer invasion
$1,893,994Andre Levchenko · Yale University · U54 · FY2018 · CA
Novel Therapeutics for Prion Diseases
$1,893,873Stanley B Prusiner · University Of California, San Francisco · P01 · FY2012 · AG
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
$1,884,922Joseph J Cullen · University Of Iowa · P01 · FY2019 · CA
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
$1,883,308E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Integrating genome-wide association study data with single-cell `omics' to reveal the cellular effectors of glioblastoma predisposition
$1,882,680Quinn T Ostrom · Duke University · R01 · FY2025 · CA
EFRI CEE: Opening the Gates of Apoptosis in Cancer
$1,879,390Stefan H Bossmann · University Of Kansas Medical Center Research Institute Inc · · FY2021 · ENG
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy
$1,877,237Christopher Chad Quarles · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
The USC-JHU Cancer Epigenome Characterization Center
$1,875,333Peter W Laird · University Of Southern California · U24 · FY2012 · CA
Genetics and Biology of Malignant Glioma
$1,875,042Dana-Farber Cancer Institute · P01 · FY2004 · CA
Molecular Profiling of Clinical Specimens
$1,874,339Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Brain Tumor Clinical and Clinical Research Program
$1,870,543Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,869,132David J Odde · University Of Minnesota · P01 · FY2022 · CA